|
|
|
Volumn 10, Issue 12, 2004, Pages 948-954
|
|
Asthma disease management: Regression to the mean or better?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
ANTIINFLAMMATORY AGENT;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
ASTHMA;
CHILD;
CONTROLLED STUDY;
COST CONTROL;
DISEASE EXACERBATION;
EMERGENCY WARD;
FEMALE;
FOLLOW UP;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HOSPITALIZATION;
HUMAN;
INVESTMENT;
MAJOR CLINICAL STUDY;
MALE;
MEDICAID;
NURSE;
PATIENT EDUCATION;
PHYSICIAN;
PRIORITY JOURNAL;
QUESTIONNAIRE;
REGRESSION ANALYSIS;
TELEPHONE;
TREATMENT OUTCOME;
UNITED STATES;
ADOLESCENT;
ADULT;
ASTHMA;
CHILD;
CHILD, PRESCHOOL;
CHRONIC DISEASE;
COST-BENEFIT ANALYSIS;
DISEASE MANAGEMENT;
FEMALE;
HEALTH CARE COSTS;
HUMANS;
INSURANCE CLAIM REPORTING;
INVESTMENTS;
MALE;
MEDICAID;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT SELECTION;
PROGRAM EVALUATION;
|
|
EID: 11144279265
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (30)
|
|
References (7)
|
